Litt’s Drug profile for Zoster Vaccine

  • Trade Name: Zostavax (Oka/Merck)
  • Indications: To reduce the risk of developing herpes zoster (in people over 60)
  • Class: Vaccine
  • Half-life: N/A
  • Clinically important, potentially hazardous interactions with:
    None known

Please login to view the rest of this drug profile.

Page last updated 08/20/2025

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top